The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu

<div>Maternal soluble HLA-G concentrations (ng/mL) in the first and second trimesters of pregnancy and at delivery in controls and GDM (a). Correlation with maternal HLA-G 14 bp insertion/deletion (ins/del) genotype in the first and second trimesters of pregnancy and at delivery in healthy mothers (controls) and GDM mothers (b). Correlation with fetal HLA-G 14 bp insertion/deletion (ins/del) genotype in the first and second trimesters of pregnancy and at delivery in healthy mothers (controls) and GDM mothers (c).</div>

Disease Markers

fig2

Figure 2

Figure 2: The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu 

Figure 2 | The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu 